272 related articles for article (PubMed ID: 16087912)
1. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.
Rupprecht TA; Pfister HW; Angele B; Kastenbauer S; Wilske B; Koedel U
Neurology; 2005 Aug; 65(3):448-50. PubMed ID: 16087912
[TBL] [Abstract][Full Text] [Related]
2. Sublime diagnosis of Lyme neuroborreliosis.
Segal BM; Logigian EL
Neurology; 2005 Aug; 65(3):351-2. PubMed ID: 16087895
[No Abstract] [Full Text] [Related]
3. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
4. [New biomarker discovered. Will the diagnosis of neuroborreliosis soon be easier (interview by Maria Weiss)?].
Rupprecht T
MMW Fortschr Med; 2009 Apr; 151(18):8. PubMed ID: 19769063
[No Abstract] [Full Text] [Related]
5. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
[TBL] [Abstract][Full Text] [Related]
6. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
[TBL] [Abstract][Full Text] [Related]
7. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
[TBL] [Abstract][Full Text] [Related]
8. Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis.
Grygorczuk S; Zajkowska J; Swierzbińska R; Pancewicz S; Kondrusik M; Hermanowska-Szpakowicz T
Rocz Akad Med Bialymst; 2005; 50():173-8. PubMed ID: 16358960
[TBL] [Abstract][Full Text] [Related]
9. Relevance of immunological variables in neuroborreliosis and multiple sclerosis.
Bednárová J; Stourac P; Adam P
Acta Neurol Scand; 2005 Aug; 112(2):97-102. PubMed ID: 16008535
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic difficulties in neuroborreliosis in children].
Talarek E; Duszczyk E; Zarnowska H
Przegl Epidemiol; 2007; 61(1):73-8. PubMed ID: 17702442
[TBL] [Abstract][Full Text] [Related]
11. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis.
Berg-Hansen P; Vandvik B; Fagerhol M; Holmøy T
J Neuroimmunol; 2009 Nov; 216(1-2):98-102. PubMed ID: 19800696
[TBL] [Abstract][Full Text] [Related]
12. Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations.
Kępa L; Oczko-Grzesik B; Sobala-Szczygieł B; Boroń-Kaczmarska A
Przegl Epidemiol; 2015; 69(4):705-10, 851-5. PubMed ID: 27139348
[TBL] [Abstract][Full Text] [Related]
13. CXCL13 chemokine in pediatric and adult neuroborreliosis.
Wutte N; Berghold A; Löffler S; Zenz W; Daghofer E; Krainberger I; Kleinert G; Aberer E
Acta Neurol Scand; 2011 Nov; 124(5):321-8. PubMed ID: 21320077
[TBL] [Abstract][Full Text] [Related]
14. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
[TBL] [Abstract][Full Text] [Related]
15. Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.
Wutte N; Archelos J; Crowe BA; Zenz W; Daghofer E; Fazekas F; Aberer E
J Neurol Sci; 2014 Dec; 347(1-2):96-103. PubMed ID: 25288328
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study.
Gyllemark P; Forsberg P; Ernerudh J; Henningsson AJ
J Neuroinflammation; 2017 Feb; 14(1):27. PubMed ID: 28148307
[TBL] [Abstract][Full Text] [Related]
17. CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients.
Wagner JN; Weis S; Kubasta C; Panholzer J; von Oertzen TJ
J Neurol; 2018 Jan; 265(1):74-81. PubMed ID: 29134272
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis.
Moniuszko A; Czupryna P; Pancewicz S; Rutkowski K; Zajkowska O; Swierzbińska R; Grygorczuk S; Kondrusik M; Owłasiuk P; Zajkowska J
Immunol Lett; 2014; 157(1-2):45-50. PubMed ID: 24239846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]